CME QUIZ
Year : 2018 | Volume
: 29 | Issue : 3 | Page : 172--173
Cme test
Correspondence Address:
How to cite this article:
. Cme test.Urol Sci 2018;29:172-173
|
How to cite this URL:
. Cme test. Urol Sci [serial online] 2018 [cited 2022 Sep 30 ];29:172-173
Available from: https://www.e-urol-sci.com/text.asp?2018/29/3/172/235386 |
Full Text
Please read this issue of Urological Science and return the postage-paid reply slip with your answers by June, 2018. A score of 80% or better will earn three CME credits.
The incidence of Infectious complications (asymptomatic UTI to septic shock) after transrectal ultrasound biopsy is?
Less than 0.11% to 4%5-10%>10%
Urol Sci 2018;29(3):129-133.
What is the median duration of metastatic prostate cancer treated with androgen deprivation therapy progressing to metastatic castration-resistant prostate cancer (mCRPC)?
<10 months11.7–16 months24-48 months48-60 months>60 months
Urol Sci 2018;29(3):136-144.
What is the risk factor of urolithiasis?
family hereditydietary habithydration status,lifestyle and environmental factorsall of the above
Urol Sci 2018;29(3):145-150.
What is the risk of prostate cancer in the patients with atypical small acinar proliferation (ASAP)
20%30%40%50%60%
Urol Sci 2018;29(2):161-165.
What is the risk of prostate cancer in the patients with high-grade prostatic intraepithelial neoplasia (HGPIN).
20%30%40%50%60%
Urol Sci 2018;29(2):161-165.
Volume 29 Issue 2
Answers:
1. (E) 2. (E) 3. (E) 4. (B) 5. (E) 6. (E)
|
